Evidence Question
What adverse-event evidence has been reported for combination therapy with benazepril and valsartan and incidence of hyperkalemia?
Short answer
The indexed evidence includes reports concerning incidence of hyperkalemia in 1 supporting study involving combination therapy with benazepril and valsartan.
Why do we say this?
This Question summarizes adverse-event reports from 1 supporting study.
Explore the evidence
Related questions
- What adverse-event evidence has been reported for combination therapy with benazepril and valsartan and incidence of hypotension?
- What does direct evidence report when benazepril monotherapy is compared with combination therapy with benazepril and valsartan for incidence of hyperkalemia?
- What does direct evidence report when combination therapy with benazepril and valsartan is compared with valsartan monotherapy for incidence of hyperkalemia?